IL17A and myeloid sarcoma: Noteworthy, it has been shown in patients suffering MS that γδ T cells accumulate in plaques and in chronically demyelinated areas of the central nervous system (CNS); and that IL-17A-producing γδ T cells increase in cerebrospinal fluids and in brain lesions (72, 73).